{"doi":null,"coreId":"12435","oai":"oai:wrap.warwick.ac.uk:34574","identifiers":["oai:wrap.warwick.ac.uk:34574",null],"title":"In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury","authors":["Perkins, Gavin D.","Nathani, N.","McAuley, Daniel F.","Smith, F. Gao (Fang Gao)","Thickett, David R."],"enrichments":{"references":[{"id":37514545,"title":"Adult respiratory distress syndrome  Articles on similar topics can be found in the following collections","authors":[],"date":null,"doi":null,"raw":"Adult respiratory distress syndrome     \u0095 Articles on similar topics can be found in the following collections","cites":null},{"id":37514544,"title":"Drugs: respiratory system","authors":[],"date":null,"doi":"10.1016\/b978-0-7216-8706-3.50036-0","raw":"Drugs: respiratory system     \u0095","cites":null}],"documentType":{"type":1}},"contributors":[],"datePublished":"2007","abstract":"Background: Intravenous salbutamol (albuterol) reduces lung water in patients with the acute respiratory\\ud\ndistress syndrome (ARDS). Experimental data show that it also reduces pulmonary neutrophil accumulation or\\ud\nactivation and inflammation in ARDS.\\ud\nAim: To investigate the effects of salbutamol on neutrophil function.\\ud\nMethods: The in vitro effects of salbutamol on neutrophil function were determined. Blood and\\ud\nbronchoalveolar lavage (BAL) fluid were collected from 35 patients with acute lung injury (ALI)\/ARDS, 14\\ud\npatients at risk from ARDS and 7 ventilated controls at baseline and after 4 days\u2019 treatment with placebo or\\ud\nsalbutamol (ALI\/ARDS group). Alveolar\u2013capillary permeability was measured in vivo by thermodilution\\ud\n(PiCCO). Neutrophil activation, adhesion molecule expression and inflammatory cytokines were measured.\\ud\nResults: In vitro, physiological concentrations of salbutamol had no effect on neutrophil chemotaxis, viability\\ud\nor apoptosis. Patients with ALI\/ARDS showed increased neutrophil activation and adhesion molecule\\ud\nexpression compared with at risk-patients and ventilated controls. There were associations between alveolar\u2013\\ud\ncapillary permeability and BAL myeloperoxidase (r = 0.4, p = 0.038) and BAL interleukin 8 (r = 0.38,\\ud\np = 0.033). In patients with ALI\/ARDS, salbutamol increased numbers of circulating neutrophils but had no\\ud\neffect on alveolar neutrophils.\\ud\nConclusion: At the onset of ALI\/ARDS, there is increased neutrophil recruitment and activation. Physiological\\ud\nconcentrations of salbutamol did not alter neutrophil chemotaxis, viability or apoptosis in vitro. In vivo,\\ud\nsalbutamol increased circulating neutrophils, but had no effect on alveolar neutrophils or on neutrophil\\ud\nactivation. These data suggest that the beneficial effects of salbutamol in reducing lung water are unrelated to\\ud\nmodulation of neutrophil-dependent inflammatory pathways","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"BMJ Group","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:wrap.warwick.ac.uk:34574<\/identifier><datestamp>\n      2017-12-22T15:31:07Z<\/datestamp><setSpec>\n      7374617475733D707562<\/setSpec><setSpec>\n      7375626A656374733D52:5243<\/setSpec><setSpec>\n      74797065733D61727469636C65<\/setSpec><setSpec>\n      636F6C6C656374696F6E3D77726170<\/setSpec><\/header><metadata><rioxx xmlns=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/\" xmlns:ali=\"http:\/\/ali.niso.org\/2014\/ali\/1.0\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:dcterms=\"http:\/\/purl.org\/dc\/terms\/\" xmlns:rioxxterms=\"http:\/\/docs.rioxx.net\/schema\/v2.0\/rioxxterms\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/ http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/rioxx.xsd\" ><ali:free_to_read>\n    \n      <\/ali:free_to_read><dc:description>Background: Intravenous salbutamol (albuterol) reduces lung water in patients with the acute respiratory\\ud\ndistress syndrome (ARDS). Experimental data show that it also reduces pulmonary neutrophil accumulation or\\ud\nactivation and inflammation in ARDS.\\ud\nAim: To investigate the effects of salbutamol on neutrophil function.\\ud\nMethods: The in vitro effects of salbutamol on neutrophil function were determined. Blood and\\ud\nbronchoalveolar lavage (BAL) fluid were collected from 35 patients with acute lung injury (ALI)\/ARDS, 14\\ud\npatients at risk from ARDS and 7 ventilated controls at baseline and after 4 days\u2019 treatment with placebo or\\ud\nsalbutamol (ALI\/ARDS group). Alveolar\u2013capillary permeability was measured in vivo by thermodilution\\ud\n(PiCCO). Neutrophil activation, adhesion molecule expression and inflammatory cytokines were measured.\\ud\nResults: In vitro, physiological concentrations of salbutamol had no effect on neutrophil chemotaxis, viability\\ud\nor apoptosis. Patients with ALI\/ARDS showed increased neutrophil activation and adhesion molecule\\ud\nexpression compared with at risk-patients and ventilated controls. There were associations between alveolar\u2013\\ud\ncapillary permeability and BAL myeloperoxidase (r = 0.4, p = 0.038) and BAL interleukin 8 (r = 0.38,\\ud\np = 0.033). In patients with ALI\/ARDS, salbutamol increased numbers of circulating neutrophils but had no\\ud\neffect on alveolar neutrophils.\\ud\nConclusion: At the onset of ALI\/ARDS, there is increased neutrophil recruitment and activation. Physiological\\ud\nconcentrations of salbutamol did not alter neutrophil chemotaxis, viability or apoptosis in vitro. In vivo,\\ud\nsalbutamol increased circulating neutrophils, but had no effect on alveolar neutrophils or on neutrophil\\ud\nactivation. These data suggest that the beneficial effects of salbutamol in reducing lung water are unrelated to\\ud\nmodulation of neutrophil-dependent inflammatory pathways.<\/dc:description><dc:format>application\/pdf<\/dc:format><dc:identifier>http:\/\/wrap.warwick.ac.uk\/34574\/1\/WRAP_Perkins_In_vitro_salbutamol.pdf<\/dc:identifier><dc:language>en<\/dc:language><dc:publisher>BMJ Group<\/dc:publisher><dc:source>Thorax<\/dc:source><dc:subject>RC<\/dc:subject><dc:title>In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury<\/dc:title><rioxxterms:author>Perkins, Gavin D.<\/rioxxterms:author><rioxxterms:author>Nathani, N.<\/rioxxterms:author><rioxxterms:author>McAuley, Daniel F.<\/rioxxterms:author><rioxxterms:author>Smith, F. Gao (Fang Gao)<\/rioxxterms:author><rioxxterms:author>Thickett, David R.<\/rioxxterms:author><rioxxterms:publication_date>2007<\/rioxxterms:publication_date><rioxxterms:type>Journal Article\/Review<\/rioxxterms:type><rioxxterms:version>NA<\/rioxxterms:version><rioxxterms:version_of_record>http:\/\/dx.doi.org\/10.1136\/thx.2006.059410<\/rioxxterms:version_of_record><\/rioxx><\/metadata><\/record>","journals":null,"language":{"code":"en","id":9,"name":"English"},"relations":[],"year":2007,"topics":["RC"],"subject":["RC"],"fullText":""}